Introduction {#s1}
============

Methyl-CpG-binding-protein 2 (MeCP2) is an abundant nuclear protein that was initially identified as the founding member of the methyl-DNA binding proteins family ([@bib30]). Mutations in the X-linked *Mecp2* gene cause Rett syndrome, a severe neurological disorder characterized by developmental regression during the first few years of life ([@bib2]). Although MeCP2 is expressed by all cell types, it is present at very high levels in neurons ([@bib49]). Loss of MeCP2 is not lethal to these cells but results in alterations in gene expression and reduced cellular growth ([@bib3]; [@bib9]). Although the consequences of MeCP2 loss are well documented, the mechanisms by which MeCP2 functions may include both the recruitment of specific epigenetic regulatory factors to select sites in the genome ([@bib9]; [@bib23]; [@bib24]; [@bib28]; [@bib37]) and a more general role as an organizer of chromatin topology in broad nuclear regions ([@bib5]; [@bib16]; [@bib32]; [@bib38]). Given the abundance of MeCP2 and its important role in the regulation of chromatin structure and gene expression, further investigation of its chromatin interactions in neurons is of interest.

Genome-wide mapping studies of MeCP2 have shown that it is enriched in highly methylated regions, although it can be found also in regions where levels of DNA methylation are low ([@bib7]; [@bib41]; [@bib49]). Oddly, despite its high expression in neurons, MeCP2 is not sufficiently abundant to bind simultaneously to all methylated sites in the neuronal genome. Hence, the mouse genome contains \~2×10^9^ cytosines in the mouse genome ([@bib43]) and 5--6% of cytokines are methylated in most cells of the adult body ([@bib20]) including granule cells ([Figure 6---figure supplement 2B](#fig6s2){ref-type="fig"}), which means that there are \~10^8^ 5 mC in each nucleus, while there are not more than 2 × 10^7^ MeCP2 molecules ([@bib49]). This suggests that the global distribution of MeCP2 observed in ChIP studies might result from summation of MeCP2-chromatin interactions that are rather sparse with respect to DNA methylation and quite dynamic. This is consistent with previous imaging studies that have employed fluorescence recovery after photobleaching (FRAP) to document the mobility of MeCP2 in the nucleus of culture cell lines ([@bib1]; [@bib18]; [@bib29]). While these indirect measurements of average MeCP2 behavior over large regions of the nucleus indicate that MeCP2 is mobile, they provide little insight into the mechanisms governing MeCP2 target site selection.

Recent single molecule imaging studies of transcription factors in living cells have yielded surprising insights into their dynamic behavior in the nucleus and revealed unanticipated features of their target search strategies that ought to be considered in models of eukaryotic gene regulation ([@bib11]; [@bib12]; [@bib35]). To gain additional insights into the dynamic behavior of MeCP2 and its interactions with neuronal chromatin, we have applied this approach to the analysis of MeCP2 in the nucleus of living neurons. Measurements of the behavior of single MeCP2 molecules in the nucleus of cerebellar granule cells relative to other well-studied nuclear proteins revealed that the binding and diffusion of MeCP2 in neurons is similar to H1 linker histones, and distinct from both core histones and site-specific transcription factors. Specifically, extensive mutagenesis experiments demonstrate that MeCP2 behavior in the nucleus can be functionally attributed to a stably bound state with short life times (\~7 s) and an unbound state with MeCP2 diffusing much slower than site-specific TFs. Interestingly, we found that the fraction of stably bound state is exquisitely sensitive to the level of DNA modification, and is altered by Rett Syndrome mutations that impact the methyl-CpG binding domain (MBD). In contrast, independent interactions governed by the three AT hook domains at the C-terminus of MeCP2 played a dominant role in regulating the diffusion of unbound MeCP2 with relatively minor contributions from MBD. Furthermore, MeCP2 mobility in the nucleus is sensitive to the local chromatin environment in granule cells, and is dramatically accelerated in the large, euchromatic nuclei of Purkinje cells. Together, our results provide a physical model to explain how distinct types of molecular interactions regulate dynamic MeCP2 binding and diffusion in the nucleus that likely impact its function.

Results {#s2}
=======

MeCP2 nuclear dynamics at single molecule resolution in cerebellar neurons reveals its unique slow diffusive behavior {#s2-1}
---------------------------------------------------------------------------------------------------------------------

To study MeCP2 at single molecule resolution in live neurons, we transfected mouse cerebellar granule cells with a construct expressing MeCP2-HaloTag fusion protein and cultured them for 12--14 days to generate a monolayer of neuronal cells that is ideal for image acquisition ([Figure 1A](#fig1){ref-type="fig"}). To measure the behavior of MeCP2 relative to other well studied nuclear proteins, we used in parallel vectors expressing the HaloTag domain fused to the histone H2b, to a small domain containing MeCP2 minimal nuclear localization signal (NLS), to the transcription factors Sox2 and TBP, and to the linker histone H1.0. The cells were then incubated with the fluorescent HaloLigand JF549 to specifically label HaloTagged proteins ([Figure 1B](#fig1){ref-type="fig"}).

![Analysis of single molecule kinetics reveals unique the slow diffusive behavior of MeCP2.\
(**A**) Schematic representation of the experimental strategy used. Cerebellar granule cells (GC) from 6 to 8 day old pups were transfected with constructs expressing the HaloTag domain in frame to MeCP2 coding sequence, or other control proteins. For MeCP2 endogenous expression, 6--8 day old MeCP2-HaloTag knock-in pups were used for granule cell culture under the same experimental conditions. Single MeCP2 molecules were imaged in live GC cultures by (**B**) specifically labeling MeCP2-HaloTag proteins with JF549-HaloLigand, (**C**) photo-bleaching at high laser power to gain sparse labeling and single molecule images were recorded at 100 Hz. (**D**) Representative single molecule tracks obtained from live granule cells nuclei for the different proteins at 100 Hz. (**E**) Distribution of diffusion coefficients (D', μm^2^/s) calculated for individual molecules assuming Brownian motion. H2b (\~20,000 molecules, blue), NLS (\~10,000 molecules, tourquise), Sox2 (\~15,000 molecules, green), TBP (\~8000 molecules, dark green), H1.0 (\~50,000 molecules, orange), Exogenous MeCP2 (\~20,000 molecules, red), and Endogenous MeCP2 (\~28,000 molecules, orange). The curves were plot stacked on a joy plot and the origins of the y axis for each curve are displaced for clarity (**F**) Fraction (Left) of bound molecules and average diffusion coefficient (Right) of the unbound molecules calculated for individual cell by fitting the SpotOn 2-state model to the distribution of translocations for individual molecules of H2b (9 cells, blue), NLS (19 cells, turquoise), Sox2 (25 cells, green), TBP (16 cells, dark green), H1.0 (19 cells, orange), Exogenous MeCP2 (20 cells, red) and Endogenous MeCP2 (23 cells, orange). Graphs show mean and standard deviation of single cell value (gray dots) and compare Exogenous MeCP2 to each of other nuclear factors by one-way ANOVA with Bonferroni's multiple comparison test: \*\*\*\* (p\<0.0001), \*(p\<0.05,\>0.01).](elife-51449-fig1){#fig1}

Two different sets of data were collected to describe the behavior of MeCP2 relative to histones and conventional transcription factors. To determine the residence time of the stably bound proteins, we acquired images from sparsely labeled nuclei at low excitation power and high acquisition time (500 ms/frame). As a result, while mobile particles are blurred into the background, immobile single molecules are selectively recorded as individual bright spots that can be followed for several frames until they dissociate from their binding sites ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). In agreement with previous studies of nuclear factors interacting with chromatin ([@bib11]), the dissociation kinetics of MeCP2 is best described by a double exponential decay that accounts for short-lived and long-lived populations of bound molecules ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}). This dwelling time analysis demonstrates that approximately \~25% of immobile MeCP2 molecules are long-lived, with residence times of \~7 s. This is shorter than the residence times of Sox2 or TBP (\~10 and\~14 s, respectively) or the linker histone H1.0 (\~10 s). The majority of MeCP2 binding interactions are shorter lived (\~2 s), as is the case with the other factors analyzed. These data demonstrate that MeCP2 engages in two different stable binding interactions with its cognate DNA sites.

To analyze the dynamic behavior of transiently bound or rapidy diffusing MeCP2 molecules, images from sparsely labeled living granule cells ([Figure 1C](#fig1){ref-type="fig"}) were acquired at very high speed (100 Hz) to generate 2D single molecule tracks of the movements of single tagged proteins in the nucleus. It is evident from these single molecule trajectories ([Figure 1D](#fig1){ref-type="fig"}) that the dynamics of MeCP2 in granule cell nuclei is quite distinct from stably bound histones (H2b) or sequence specific transcription factors (Sox2 and TBP). Rather, even at this superficial level of inspection, the behavior of MeCP2 and the linker histone H1.0 appear similar. This impression is confirmed by calculation of the distribution of diffusion coefficients calculated for each of these nuclear proteins, revealing their similarity to one another relative to Sox2, TBP, histone H2B, or the NLS control ([Figure 1E](#fig1){ref-type="fig"}).

To better evaluate the distinctive diffusive properties of MeCP2 molecules, we used the algorithm package Spot-On ([@bib21]). At this high rate of image acquisition, the long and short-lived stably bound proteins revealed in the residence time measurements cannot be distinguished from one another, and both are included in the bound fraction because their diffusion constants are very slow.

Spot-On derives the fraction of stably bound molecules, those that diffuse \<0.08 μm^2^/s, and also calculates the diffusion coefficient of those that are unbound and rapidly moving ([Figure 1F](#fig1){ref-type="fig"}). As expected given their stable incorporation into nucleosomes, the vast majority of H2b molecules (\>80%) are immobile, while most of the NLS molecules (80--90%) are very rapidly diffusing (\~4 μm^2^/s). As previously shown, a minority of Sox2 and TBP molecules are stably bound. Diffusion of unbound Sox2 and TBP proteins is relatively rapid and similar to that previously reported in ES cells, averaging \~2 and 1.5 μm^2^/s per cell respectively, ([Figure 1F](#fig1){ref-type="fig"}) ([@bib11]). These data confirm the general rule for sequence-specific transcription factors that less than half of the population is stably bound to DNA, and the rest moves rapidly 'searching' chromatin to find cognate binding sites. Two features distinguish the dynamic behavior of MeCP2 from transcription factors ([Figure 1F](#fig1){ref-type="fig"}). First, the fraction of MeCP2 molecules bound in a stable mode is significantly higher than that of Sox2 or TBP. Thus, approximately half of the MeCP2 population is stably bound in granule cell nuclei at any given time. Second, when not bound stably, MeCP2 diffuses significantly more slowly (averaging \~1 μm^2^/s per cell) than Sox2, TBP or the NLS proteins. Interestingly, the dynamic behavior of MeCP2 is strikingly similar to the linker histone H1.0, where \~ 50% of molecules are immobile and unbound molecules diffuse slowly inside the nucleus (\~1 μm^2^/s per cell) ([Figure 1F](#fig1){ref-type="fig"}).

MeCP2 nuclear dynamics do not depend on its expression level {#s2-2}
------------------------------------------------------------

MeCP2 gene dosage is critical for normal neuronal function ([@bib14]; [@bib45]). To establish that the slow diffusive properties we have measured reflect the properties of endogenous MeCP2, we generated a mouse line genetically engineered to harbor an in-frame sequence encoding the HaloTag domain in the 3' UTR of *Mecp2* gene ([Figure 1---figure supplement 2A and B](#fig1s2){ref-type="fig"}). Animals expressing the MeCP2-HaloTag fusion protein are viable and show no disease phenotype, demonstrating that the HaloTag domain does not disrupt MeCP2 physiological function. Single molecule tracks of endogenous MeCP2 imaged in granule cells cultured from the knock-in mice resemble those generated by exogenously expressed proteins ([Figure 1D](#fig1){ref-type="fig"}). Furthermore, the distributions of diffusion coefficients for individual molecules of exogenous and endogenous MeCP2 strongly overlap ([Figure 1E](#fig1){ref-type="fig"}). Both the bound fraction and the rate of diffusion of the unbound molecules calculated for single cells do not differ significantly between the two conditions ([Figure 1F](#fig1){ref-type="fig"}), indicating that endogenous and exogenous MeCP2 have identical nuclear dynamics in granule cells.

As an additional control to directly demonstrate identical dynamic properties of endogenous and exogenously introduced MeCP2, we co-cultured MeCP2-HaloTag granule cells transfected with a vector expressing a MeCP2-GFP fusion protein with untransfected MeCP2-HaloTag granule cells ([Figure 1---figure supplement 3A](#fig1s3){ref-type="fig"}). In this way, MeCP2 molecules could be acquired from cells expressing them at endogenous level (GFP negative) and, in parallel from cells containing additional copies of exogenously expressed MeCP2 proteins (GFP positive, [Figure 1---figure supplement 3B](#fig1s3){ref-type="fig"}). No difference between these two conditions could be detected in the distribution of MeCP2 diffusion coefficients ([Figure 1---figure supplement 3C](#fig1s3){ref-type="fig"}), the fraction of bound molecules or diffusion rate of unbound molecules per cell ([Figure 1---figure supplement 3D](#fig1s3){ref-type="fig"}). Furthermore, the dwell time analysis revealed comparable behavior for MeCP2 regardless of the expression system ([Figure 1---figure supplement 3E](#fig1s3){ref-type="fig"}).

Taken together, our data demonstrate that the dynamic behavior of MeCP2 in granule cell nuclei is distinct from both stably bound histones and typical sequence-specific transcription factors. It is also established that both the endogenously and exogenously expressed MECP2-HaloTag proteins are suitable for in depth investigation of both its bound state, and the factors contributing to the peculiar, slow diffusion of unbound MeCP2 in neuronal nuclei.

MeCP2 chromatin binding is sensitive to DNA modification levels in neurons {#s2-3}
--------------------------------------------------------------------------

Biochemical studies initially determined that the ability of MeCP2 to bind DNA depends on the presence of methylated cytosines (5mC) ([@bib30]) and more recently, it was shown that hydroxylation of these sites (5hmC), when it occurs in the context of CpG, disrupts this interaction ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}) ([@bib4]; [@bib17]; [@bib41]). Once neurons become postmitotic, they begin accumulating de novo DNA methylation sites by the activity of DNA methyltransferase 3a (DNMT3a), as well as converting 5mC to 5-hyroxymethylcytosine (5hmC) through the enzymes Tet1, 2 and 3 ([@bib33]; [@bib50]). To understand the relationship between these DNA modifications and MeCP2 dynamics in live granule cells, we removed these epigenetic factors using appropriate conditional alleles and Cre drivers, and we observed MeCP2 behavior by expressing Double-floxed Inverted Orientation (DIO) MeCP2-HaloTag ([Figure 2A](#fig2){ref-type="fig"}).

![DNA modifications regulate MeCP2 binding without affecting its nuclear diffusion.\
(**A**) Schematic representation of the experimental design. Cre-dependent expression vector carrying DIO-MeCP2-HaloTag was transfected in GC cultures from Neurod1-cre (wild type) or Neurod1-cre;Dnmt3a^flox/flox^ (Dnmt3a_cKO) animals. Cre-expressing vector was co-transfected with DIO-MeCP2-HaloTag construct in GC culture from Tet1^flox/flox^;Tet2^flox/flox^; Tet3^flox/flox^ animals (Tets_cKO (**B**) Fraction of bound molecules and diffusion coefficient of the unbound molecules calculated for individual cells by SpotOn in wild type (22 cells), Dnmt3a depleted (7 cells) and Tet1, 2 and 3 triple knock-out (29 cells) GCs. Graphs show mean and standard deviation of single cell values (gray dots) and compare wild type neurons to mutants by one-way ANOVA with Bonferroni's multiple comparison test: \*\* (p\<0.005); \*\*\* (p\<0.0005).](elife-51449-fig2){#fig2}

We employed the Neurod1 Cre driver line in Dnmt3a^flox/flox^ animals to generate granule cells lacking de novo DNA methylation (Neurod1Cre;Dnmt3a^flox/flox^, Dnmt3a_cKO, [Figure 2A](#fig2){ref-type="fig"}), which resulted in \~20% decrease of total 5mC level in both CG and non-CG sequence contexts ([Figure 2---figure supplement 1B,C,D and E](#fig2s1){ref-type="fig"}). MeCP2 nuclear trajectories recorded in these hypo-methylated granule cells display increased mobilty as shown by cumulative distribution of D' values for individual molecules ([Figure 2---figure supplement 1G](#fig2s1){ref-type="fig"}). The fraction of bound MeCP2 in the Dnmt3a KO cells decreased from \~55% to\~45%, in agreement with the \~20% depletion of DNA methylation in these cells (decrease from \~6% to 5% of all cytosines, [Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}). In contrast, the rate of diffusion of unbound MeCP2 molecules is largely unaffected by this decrease in DNA methylation ([Figure 2B](#fig2){ref-type="fig"}).

To prevent DNA oxidation of 5mC to 5hmC in granule neurons, we depleted the three Tet oxidases by transfecting a Cre expressing vector in cultured granule cells from Tet1^flox/flox^;Tet2^flox/flox^; Tet3^flox/flox^ animals ([@bib31]) ([Figure 2A](#fig2){ref-type="fig"}). Because a DIO-MeCP2-HaloTag construct was co-transfected into these cells, MeCP2-HaloTag could only be observed in cells with impaired Tet activity (Tets_cKO) and in turn devoid of 5hmC sites ([Figure 2---figure supplement 1F](#fig2s1){ref-type="fig"}). Loss of expression of Tet proteins results in a subtle reduction in MeCP2 nuclear mobility as observed by the distribution of diffusion coefficients for individual molecules ([Figure 2---figure supplement 1G](#fig2s1){ref-type="fig"}). While the diffusion of unbound MeCP2 molecules remains essentially unchanged in cells lacking 5hmC, the fraction of bound molecules increases from \~55% to\~60%, ([Figure 2B](#fig2){ref-type="fig"}). This is consistent with the higher number of high affinity 5mCG binding sites expected as a result of the failure to convert them to low affinity 5hmCG sites. We note that the small magnitude of this change is not surprising since less than 0.5% of all cytosines are hydroxylated in the granule cell genome ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}).

Taken together, these data suggest that MeCP2 behavior in live neurons is tightly regulated by epigenetic modifications of the DNA. Thus, as predicted from previous biochemical studies ([@bib30]; [@bib41]), a decrease in the level of DNA methylation as a result of Dnmt3a deletion causes a reduction in the fraction of stably bound MeCP2 in vivo. Conversely an increase in DNA methylation as a consequence of deletion of the Tet oxidases results in an increase in the fraction of stably bound MeCP2. The slow rate of diffusion of unbound MeCP2 in vivo is not dependent on DNA methylation and, therefore, must reflect distinct biochemical properties of MeCP2.

MeCP2 MBD is required for stable binding and constrains its diffusion in granule cell nuclei {#s2-4}
--------------------------------------------------------------------------------------------

To investigate further the contribution of DNA binding to MeCP2 dynamic behavior, we targeted the MBD domain with two common Rett syndrome mutations, known to disrupt MeCP2 DNA binding to different degrees ([@bib15]): R106W, which completely abolishes DNA binding and R133C which retains significant DNA binding capacity ([@bib44]). R106W-HaloTag DIO and R133C-HaloTag DIO were expressed in cultured NeuroD1Cre+ granule cells in parallel with wild type MeCP2 ([Figure 3A](#fig3){ref-type="fig"}). As expected, given their distinct DNA binding properties, the two MeCP2 mutants display different behaviors in the nucleus of cultured granule cells. The nuclear distribution of R106W appears homogenous in the nucleus of granule cells, and its nuclear trajectories differ dramatically from wild type. In contrast, the distribution of R133C in the nucleus and its single molecule tracks resemble wild type MeCP2 ([Figure 3B](#fig3){ref-type="fig"}).

![Rett-syndrome mutations within the MBD domain disrupt MeCP2 nuclear kinetics.\
(**A**) Schematic representation of the experimental design. GC culture of Neurod1-cre animals were transfected with DIO constructs carrying wild type MeCP2-HaloTag (red) or bearing the Rett-syndrome mutations Arginine 133 to Cysteine (R133C, green) or Arginine 106 to Tryptophan (R106W, blue). (**B**) Cells labeled with JF549- HaloLigand show the nuclear distribution of wild type MeCP2HaloTag and its mutants (top panels). Representative single molecule tracks of wild type (red) R133C (green) and R106W (blue) in wild type granule cell nuclei. (**C**) Distribution of diffusion coefficients (D', μm^2^/s) calculated for individual molecules of wild type MeCP2 (\~18,000 molecules, red), R133C (\~16,000 molecules, green) and R106W (\~20,000 molecules, blue). Two-sample Kolmogorov-Smirnov test was used to compare wild type MeCP2 with R106W (p-value\<9.7e^−70^) and R133C molecules (p-value=9.7e^−29^). (**D**) Fraction of bound molecules and average diffusion coefficient of the unbound molecules calculated in individual cells for wild type MeCP2 (5 cells, red), R1033C (19 cells, green) and R106W (20 cells, blue). Graphs show mean and standard deviation of single cell values (gray dots) and compare wild type MeCP2 to Rett-syndrome mutants by one-way ANOVA with Bonferroni's multiple comparison test: \* (p\<0.05), \*\*\*\* (p\<0.0001).](elife-51449-fig3){#fig3}

Quantitative analyses of the behavior of single molecules for each of these forms of MeCP2 confirm these observations ([Figure 3B,C,D](#fig3){ref-type="fig"}). The distribution of diffusion coefficients calculated for individual molecules shows that both mutations result in increased MeCP2 mobility, but to different extents. In particular, SpotOn analysis of R106W molecules demonstrates that the loss of DNA binding capacity in this mutant strongly decreases the fraction of stably bound protein and results in a significant increase in its rate of diffusion in the nucleus (from \~1 μm^2^/s to \~1.4 μm^2^/s).

The behavior of the R133C mutation is quite different. As anticipated from its nuclear distribution and the appearance of its single molecule nuclear trajectories, the fraction of stably bound R133C does not differ significantly from wild type MeCP2. Interestingly, however, subtle differences in the rate of diffusion of the unbound R133C protein can be observed. This is apparent from both the shift in distribution of the diffusion constants presented in [Figure 3C](#fig3){ref-type="fig"}, and the trend toward an increased average diffusion coefficient for the entire population from \~1 μm2/s to \~1.2 μm2/s ([Figure 3D](#fig3){ref-type="fig"}). These experiments confirm the expectation that stable binding of MeCP2 in living nuclei requires the MBD, and they suggest that the MBD may also participate in interactions that constrain its diffusion when it is not stably bound to DNA, perhaps as it samples potential sites for stable binding.

MeCP2 AT-Hook domains constrain diffusion without affecting DNA binding {#s2-5}
-----------------------------------------------------------------------

The finding that diffusion of unbound MeCP2 resembles the slow diffusion of histone H1.0 rather than the rapid diffusion typical of unbound conventional transcription factors prompted us to investigate which domains of MeCP2 contribute to this interesting behavior. The MBD is encoded by less than 25% of the MeCP2 sequence and structural studies have revealed that most of the protein is composed of Intrinsically Disordered Domains (IDDs) ([Figure 4A](#fig4){ref-type="fig"}). Rett syndrome nonsense mutations involve many domains outside of the MBD ([Figure 4A](#fig4){ref-type="fig"}) ([@bib26]), in agreement with previous studies establishing the importance of several of these in MeCP2 interaction with chromatin and function ([@bib19]; [@bib38]). In addition to three small AT-Hook domains, MeCP2 IDDs comprise the N-terminal sequence (N-term), an Intervening domain (ID) which connects MBD to the Transcriptional Repressive Domain (TRD), containing the nuclear localization signal (NLS) and the NCoR interaction domain (NID), and a C-terminal domain (C-term). To examine the impact of these domains on MeCP2 dynamics in living neuronal nuclei, we transfected Neurod1Cre+ cerebellar granule cells with DIO constructs expressing the HaloTag in frame with several IDD depleted versions of MeCP2 protein in parallel with full-length wild type MeCP2 as a control ([Figure 4B](#fig4){ref-type="fig"}). Cultured granule cells expressing these constructs were imaged in the same experimental conditions described above to generate single molecule trajectories, which were then analyzed to measure the fraction of stably bound molecules and the diffusion rate of unbound molecules ([Figure 4C](#fig4){ref-type="fig"}).

![MeCP2 AT-Hook Domains hinder its nuclear diffusion without affecting its binding.\
(**A**) (Top) Schematic representation of full-length MeCP2 protein where known domains are annotated and the 3 AT-Hook domains are highlighted in purple. (Middle) Heat map representing protein sequence identity (from blue, high identity score, to white, no identity) between Human, Mouse, Rat and Dog MeCP2. (Bottom) Missense and nonsense Rett-syndrome causing mutation from RettBASE are annotated in red. (**B**) Diagrams of different DIO constructs used in the experiment, where MeCP2 was sequentially mutated. (**C**) Fraction of bound molecules and average diffusion coefficient of the unbound molecules calculated in individual cells by SpotOn for the different MeCP2 constructs. Full-length (red, 29 cells), Minimal (orange, 31 cells), Minimal R106W (cyan, 25 cells), +N-term (light green, 17 cells), +ID (green, 32 cells), + AT-Hook 2 (dark green, 27 cells), +NID (blue, 26 cells), +AT-Hook3 (dark blue, 11 cells), R106W-ΔAT-Hooks (purple, 32 cells). Graphs show mean and standard deviation of single cell values and compare the different constructs by two-tailed unpaired t-test: \*\*\*\* (p\<0.0001).](elife-51449-fig4){#fig4}

Minimal MeCP2 proteins containing only the MBD and NLS maintains the level of DNA binding relative to wild type control, but when unbound they diffuse significantly faster (\~1.5 μm2/s) than full-length MeCP2 (\~1 μm2/s). This confirms that the MBD is sufficient for stable DNA binding in vivo, and indicates that additional IDDs are involved in weak interactions that limit MeCP2 nuclear diffusion but do not contribute significantly to stable binding. Introduction of the inactivating R106W mutation into the MBD of this minimal construct reduces stable binding to background levels, and increases further the diffusion of unbound molecules (\~2 μm2/s). When taken together with the effects of the R106W and R133C MBD mutations on full length MeCP2, these data demonstrate that the MBD is necessary and sufficient for stable DNA binding in granule cells, that it partially constrains diffusion of unbound MeCP2, and that additional domains of the protein must also contribute to the diffusive properties of MeCP2.

To identify additional domains of MeCP2 that determine its slow diffusion in living granule cell nuclei, we progressively added individual IDDs back to the minimal R106W protein and measured their effects on MeCP2 nuclear diffusion. The addition of the N-terminal domain (+N-term) does not change the dynamic behavior of the protein. Inclusion of the ID domain (+ID), which contains an AT-hook domain, significantly reduces diffusion of unbound molecules. The incorporation of a five amino acid sequence (RGRKP) at residue 268 reconstitutes a second AT-hook domain (+AT-Hook2) but does not affect MeCP2 diffusion rate. However, if AT-hook2 is assayed independently by in-frame fusion to the rapidly diffusing NLS-HaloTag molecules, it is capable of slowing diffusion in granule cell nuclei. ([Figure 4---figure supplement 1A,B and C](#fig4s1){ref-type="fig"}). The inclusion of the NID domain further constrains MeCP2 nuclear mobility to a diffusion rate comparable to full length R106W proteins (\~1.4 μm^2^/s). Restoration of the full-length protein with the addition C-terminal domain, including a third AT-hook, does not affect MeCP2 diffusion ([Figure 4C](#fig4){ref-type="fig"}). Finally, since there is a great deal of evidence that MeCP2 AT-hook domains play a significant role in its function ([@bib5]; [@bib48]), we tested whether these alone were sufficient to determine the slow diffusion rate of unbound MeCP2. Surprisingly, the full length R106W protein lacking all three AT-hooks displays identical dynamic behavior to the minimal R106W protein that solely contains a non-functional MBD ([Figure 4C and D](#fig4){ref-type="fig"}). Taken together, these results demonstrate that the IDDs of MeCP2 are not required for stable DNA binding in the nucleus of granule cell neurons. Rather, we find that they engage in weak, transient interactions with genomic DNA or chromatin. In particular, our data highlight the MeCP2 AT-hook domains as important players in the constraint of MeCP2 diffusion in the nucleus.

MeCP2 nuclear dynamics are sensitive to the level of chromatin compaction {#s2-6}
-------------------------------------------------------------------------

The structure function studies we have presented demonstrate that the dynamic behavior of MeCP2 in the nuclei of living granule cells resembles the linker histone H1.0, that it is sensitive to DNA modifications, and that it depends on both its MBD and the IDDs. The MBD is sufficient for stable binding of MeCP2 in the nucleus, and independently contributes to its slow diffusion when unbound. By contrast, the AT-hook domains of MeCP2 provide major constraints to the mobility of unbound MeCP2 in granule cells, without generating significant stable binding. Since these domains are known to mediate non-specific interactions that occur in the minor groove of AT-rich DNA independently from DNA methylation, and MBD engages in specific binding to methylated cytosines, the behavior of MeCP2 is most likely the result of a combination of specific and non-specific interactions. Given the increased DNA concentration and the enrichment of methylated DNA in highly compact heterochromatin, we next tested the diffusive properties of MeCP2 in euchromatic and heterochromatic domains of the granule cell nucleus.

To identify compact chromatin domains in living nuclei, we transfected a fusion of heterochromatin protein one alpha (HP1α) in frame with the Blue Fluorescent Protein (HP1α-BFP) in MeCP2-HaloTag granule cells. In this way, it is possible to identify regions in the nucleus of living neurons that are highly compact (heterochromatic, HP1α positive) or more loosely arranged (euchromatic, HP1α negative) ([Figure 5A](#fig5){ref-type="fig"}). From snapshot acquisitions of HP1α-BFP signal we generated filtering masks, which allowed us to discriminate single molecule tracks recorded within heterochromatin (inside the mask, red), and those occurring within euchromatin (outside the mask, green) ([Figure 5B](#fig5){ref-type="fig"}). Although the differences in the two nuclear sub-regions are not large enough to be assessed at the population level ([Figure 5E](#fig5){ref-type="fig"}), the distributions of the diffusion coefficients of individual molecules show that euchromatic MeCP2 molecule are significantly more dynamic than those present in heterochromatin ([Figure 5C](#fig5){ref-type="fig"}) even when the two regions a compared within the same cell ([Figure 5D](#fig5){ref-type="fig"}). Furthermore, dwell time analysis shows that while MeCP2 residence times remain unchanged, the fraction of long-lived bound molecules is significantly higher in heterochromatin than euchromatin, consistent with the elevated number of MeCP2 binding sites ([Figure 5F](#fig5){ref-type="fig"}).

![MeCP2 diffusion in euchromatin and heterochromatin regions.\
(**A**) GC culture of MeCP2HaloTag animals was transfected with a construct expressing HP1αBFP (blue) and labeled with JF549-HaloLigand (red). (**B**) Nuclear single molecule tracks are spatially filtered through masks generated from whole MeCP2HaloTag-JF549 fluorescence signal to separate them into euchromatin (green) and heterochromatin (red). (**C**) Distribution of diffusion coefficients (D', μm^2^/s) calculated for individual MeCP2 molecules in euchromatin (\~22,000 molecules, green) or in heterochromatin (9000 molecules, red) of live granule cell nuclei. Two-sample Kolmogorov-Smirnov test was used to compare MeCP2 molecules in euchromatin and heterochromatin p-value=4.6e^−22^ (**D**) Scatter dot plot of Diffusion coefficients (D', μm^2^/s) for inidvidual molecules in euchromatin (green) and heterochromatin (red) within the same cells. Two-sample Kolmogorov-Smirnov test was used to compare MeCP2 molecules in euchromatin and heterochromatin: \* (p\<0.05), \*\* (p\<0.005). (**E**) Bound fraction and average diffusion coefficients of the unbound molecules calculated in each cell by SpotOn for MeCP2 in euchromatin (E, green) and heterochromatin (H, red) for 15 cells. Graphs show mean and standard deviation of single cell values (gray dots) and compare MeCP2 euchromatin and heterochromatin regions by two-tailed unpaired t-test: ns (p\>0.05). (**F**) Dwell time analysis of stable MeCP2 particles as described in [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"} in euchromatic and heterochromatic nuclear sub-regions. Graph show Long-lived fraction (left) and resident time of the Long-lived molecules (right) of stable MeCP2 for three independent replicates. Graphs show mean and standard deviation and compare Heterochromatin and Euchromatin by two-tailed unpaired t-test: \* (p\<0.05).](elife-51449-fig5){#fig5}

MeCP2 mobility depends on the cell type and nuclear architecture {#s2-7}
----------------------------------------------------------------

Despite the very compact nature of granule cell nuclei, we observed subtle differences in MeCP2 dynamic behavior that correlate with the level of chromatin compaction. To further probe this observation, and to determine whether the properties of MeCP2 change in cell types whose nuclear architecture varies significantly from granule cells, we chose to compare its behavior in granule cells and Purkinje cells ([Figure 6A](#fig6){ref-type="fig"}, [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). We prepared acute slices from the cerebellum of the MeCP2-HaloTag animals, incubated them with the JF549 ligand, and imaged MeCP2 single molecule trajectories in granule cells and Purkinje cells using lattice light sheet microscopy ([@bib10]).

![Different MeCP2 dynamic behavior in Granule and Purkinje cells from acute brain slices.\
(**A**) Representative Granule and Purkinje cell nuclei in acute cerebellar brain slices from MeCP2-HaloTag adult mice labeled with JF549-HaloLigand. (**B**) Cumulative distribution of diffusion coefficients in the logarithmic scale (D', μm^2^/s) calculated for individual MeCP2 molecules in Granule (red) and Purkinje nuclei (orange) from acute cerebellar brain slice. Two-sample Kolmogorov-Smirnov test was used to compare the Diffusion Coefficient calculated for individual MeCP2 molecules in Purkinje and Granule cells. p-value 4.79e^−68^ (**C**) Fraction of bound molecules and average diffusion coefficient of the unbound molecules of MeCP2 determined in individual granule cells (GC) and Purkinje cells (PC). Graphs show mean and standard deviation of single cell values (gray dots) comparing the two cell types by two-tailed unpaired t-test: \* (p\<0.05), \*\*\*\* (p\<0.0001).](elife-51449-fig6){#fig6}

The dynamic features of MeCP2 in granule cells from acute cerebellar slices are remarkably similar to culture experiments. Although the fraction of stably bound MeCP2 is slightly higher in the acute slices prepared from adult mice compared to cultured granule cells, the slow diffusion of unbound MeCP2 is indistinguishable in the two conditions ([Figure 6](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). The dynamic behavior of MeCP2 in the large, euchromatic nuclei of Purkinje cells is very different. As is evident from the distinct appearance of single molecule tracks in Purkinje cells ([Figure 6A](#fig6){ref-type="fig"}), the cumulative distribution of the diffusion coefficients for individual molecules in Purkinje cells demonstrates that MeCP2 is significantly more mobile in the large, euchromatic Purkinje cell nuclei ([Figure 6B](#fig6){ref-type="fig"}). Furthermore, while the fraction of stably bound MeCP2 molecules is similar between these cell types (70 vs. 60%), unbound MeCP2 diffuses considerably faster (\~2X) in PC than it does in GC ([Figure 6C](#fig6){ref-type="fig"}). Finally, the dwell time analysis shows a higher fraction of long-lived immobile molecules in GC compared to PC ([Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}). These data demonstrate that nuclear architecture and chromatin compaction play major roles in the dynamic behavior of MeCP2, and suggest that differences in these properties between cell types may influence MeCP2 function in as yet unexplored ways.

Discussion {#s3}
==========

Recent single molecule imaging studies have provided important insights into transcription factor activity that complement those obtained from biochemical, genomic and ensemble imaging studies ([@bib11]; [@bib35]). Here we have adopted this approach to measure the dynamic behavior of the fundamentally important neuronal methyl-CpG binding protein (MeCP2) in live neurons. The data we have collected both confirm previous studies of the structure and function of MeCP2, and reveal interesting new features that are important to consider in models of its roles in neuronal nuclei.

The dynamic behavior of MeCP2 in granule cells resembles histone H1.0 but is highly sensitive to the level of DNA methylation {#s3-1}
-----------------------------------------------------------------------------------------------------------------------------

Previous studies using FRAP have reported that in cultured cell lines the overall mobility of MeCP2 and histone H1.0 are similar ([@bib18]). Our measurements from single molecule imaging experiments of both endogenous and exogenously expressed MeCP2 in primary cultures of cerebellar granule neurons, as well as in acute slice preparations from adult mouse cerebellum, confirm and extend these observations. The analysis of individual nuclear trajectories demonstrates that both H1.0 and MeCP2 are less stable than the core histone H2b, but are not as mobile as sequence specific transcription factors Sox2 and TBP. Although similarly to Sox2 and TBP only a fraction of MeCP2 and H1.0 is immobile in neuronal nuclei, the rates of diffusion of the unbound molecules are much slower than these transcription factors, indicating that MeCP2 and H1.0 are somehow more productively and continuously engaging in interactions with chromatin ([Figure 1](#fig1){ref-type="fig"}). Despite the similar, constrained diffusion of MeCP2 and histone H1.0, a larger fraction of MeCP2 is engaged in long-term stable binding events than H1.0, although its residence time when stably bound is significantly shorter ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}).

In contrast to linker histones, MeCP2 binding is strongly regulated by DNA methylation. While it can interact non-specifically with DNA with low affinity, MeCP2 high affinity interactions depend on the presence of 5mC sites ([@bib7]; [@bib39]), which are masked by conversion to 5hmC ([@bib41]). ChIP assays from fixed neuronal tissue and native genome wide mapping studies have shown that MeCP2 genome occupancy in neurons is cell type specific and correlated with the status of cytosine modification ([@bib41]). The live cell imaging data we present here confirm these results, and reveal that the behavior of single MeCP2 molecules in neuronal nuclei respond quantitatively to alterations in DNA modification. Thus, without affecting the diffusion of unbound molecules, the balance of Dnmt3a and Tet activities tightly modulates the amount of available high affinity binding sites and dictates the magnitude of stably bound MeCP2 molecules in each cell ([Figure 2](#fig2){ref-type="fig"}).

The fact that the fraction of MeCP2 bound stably in live neurons is very sensitive to alterations in high affinity 5mC binding sites, despite their large excess (\~10X) in the genome relative to the number of MeCP2 molecules, indicates that MeCP2 dynamic behavior is determined by the probability of encountering these targets relative to low affinity sites rather than by the absolute levels of DNA methylation. This suggests that epigenetic modifications accumulating on the DNA of postmitotic neurons determine the local enrichment, and presumably function, of MeCP2 in neuronal nuclei.

Different aspects of MeCP2 dynamic behavior are governed by distinct protein domains {#s3-2}
------------------------------------------------------------------------------------

Several functional domains have been identified previously in MeCP2 and shown to play important roles in vivo and in vitro ([@bib5]; [@bib19]; [@bib22]; [@bib55]). Here we have examined the contributions of these domains to the dynamic behavior of single MeCP2 molecules in live granule cell nuclei, revealing several interesting features of MeCP2 that have not been reported previously.

### The MeCP2 Methyl-CpG Binding Domain {#s3-2-1}

Several mutations that cause Rett Syndrome disrupt high affinity binding of MeCP2 to DNA ([@bib6]; [@bib58]). The R106W mutation, which has been reported previously to eliminate high affinity binding of MBD ([@bib6]) and to result in a very severe clinical outcome ([@bib15]), dramatically decreases the binding of MeCP2 in live neurons whether in the context of the intact protein or a minimal MBD isoform ([Figures 3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}). Interestingly, this single point mutation also increases the diffusion of unbound MeCP2, indicating that the MBD also constrains movement of MeCP2 in the nucleoplasm. Mutation R133C causes a mild form of Rett Syndrome ([@bib15]), and has a rather attenuated phenotype when knocked in to the mouse genome ([@bib8]; [@bib40]). In our single molecule studies in live neurons, this mutation has no discernable effect on the fraction of MeCP2 bound stably to DNA. Rather, R133C alters the rate of diffusion of MeCP2 when not stably bound in vivo. This agrees with prior studies indicating that R133C does not disrupt high affinity binding to methylated DNA ([@bib40]; [@bib8]), and provides additional support for a role of the MBD in constraining the movement of unbound MeCP2 suggesting that alterations in the dynamic behavior of MeCP2 when not stably bound to DNA may also have important functional consequences in its mode of diffusion.

### The MeCP2 Intrinsically Disordered Domains {#s3-2-2}

Numerous studies have shown that MeCP2 requires both an intact MBD and its C-terminal intrinsically disordered domains (IDDs) to execute its function ([@bib38]). Here we show that MeCP2 lacking IDDs maintains its DNA binding properties, but diffuses faster, indicating that the MBD is sufficient to bind high affinity target sites while IDDs likely engage in low affinity interactions, possibly with DNA as well as other proteins in the nucleus. To assess which of these additional domains of MeCP2 are important for determining its dynamic properties in granule cell nuclei, we have assayed their independent contributions in the context of the R106W MBD mutation that eliminates stable DNA binding. The inclusions of the Intervening Domain (ID) and the NCoR/SMRT Interaction (NID) are sufficient to restore the slow rate of diffusion of the full-length protein ([Figure 4](#fig4){ref-type="fig"}), corroborating previous studies showing that ID binds non-specifically to DNA at low affinity ([@bib13]; [@bib19]) and that the NID domain is an important hub for the recruitment of epigenetic factors ([@bib37]) or directly interacts with AT-rich DNA trough its basic cluster ([@bib22]; [@bib42]). This is also in agreement with previous reports showing by FRAP that ID and NID (TRD) contribute to MeCP2 slow dynamic behavior in culture cell lines ([@bib29]).

### The MeCP2 AT-Hook Domains {#s3-2-3}

In the C-terminal portion of its amino acid sequence, MeCP2 contains three small AT-hook DNA binding domains within and surrounding the ID and NID ([Figure 4A](#fig4){ref-type="fig"}). Earlier investigations of these domains have demonstrated that they are involved with MeCP2 function ([@bib5]) and, similar to other AT-hook domains, interact preferentially with AT rich DNA ([@bib46]). Here we have shown that these low affinity interactions alone can determine the slow diffusion of MeCP2 in granule cells. Thus, lack of AT-hooks eliminates ID and NID contributions to MeCP2 dynamic behavior, indicating that ID requires AT-hook one to bind DNA and that NID requires at least two AT-hook domains to assemble protein complexes independently from MBD ([Figure 4](#fig4){ref-type="fig"}). This demonstrates that the AT-hook domains are critically important determinants influencing the dynamic behavior of MeCP2 in living neurons, and they strongly support the hypothesis that they play an important role in MeCP2 function ([@bib5]).

MeCP2 dynamic behavior is sensitive to local chromatin structure {#s3-3}
----------------------------------------------------------------

The dynamic behavior of MeCP2 in granule cell nuclei results from both high affinity specific interactions with methylated DNA and non-specific low affinity interactions with chromatin. The probability of encountering these targets in the nucleoplasm determines MeCP2 behavior, and maximizes transient local interactions as MeCP2 samples DNA for its high affinity binding sites. Granule cell nuclei are among the most compact in the nervous system. Active regions of the granule cell genome are euchromatic, and they are interspersed with large regions of highly compact, inactive heterochromatin. Surprisingly, MeCP2 binding and mobility in euchromatin and heterochromatin is very similar. Although the average diffusion coefficient of MeCP2 molecules is lower in heterochromatin than in euchromatin ([Figure 5C and D](#fig5){ref-type="fig"}), there is little apparent impact on the fraction of stably bound MeCP2 or residence times in these different chromatin domains ([Figure 5E and F](#fig5){ref-type="fig"}).

In light of the very subtle differences we have observed in MeCP2 dynamics in granule cell heterochromatin and euchromatin, we were surprised at the dramatic differences in MeCP2 dynamic behavior we observed in the large, euchromatic nuclei of Purkinje cells. While the decrease in the fraction of bound MeCP2 in Purkinje cells can be explained by the decrease in methylation and increase in hydroxymethylation of Purkinje cell DNA ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}), the rapid diffusion of unbound MeCP2 in live Purkinje cell nuclei resembles that of conventional sequence specific transcription factors shown here and in other studies ([@bib11]) rather than the H1.0-like slow diffusion evident in granule cells.

Although the functional consequences of these differences in the dynamic behavior of MeCP2 in neurons with different nuclear architectures remain to be investigated, our data suggest that the consequences of specific MeCP2 mutations may vary substantially between cell types ([@bib27]; [@bib51]). For example, in the compact small nuclei typical of granule cells, interneurons and glia, the functions of the IDD may be dominated by its three AT-hook domains. These impart its linker histone like diffusive properties, and they may reflect dynamic roles in chromatin organization that are quite distinct from those conveyed by its stable binding to high affinity sites. In the large nuclei typical of Purkinje cells, long-range projection neurons and motor neurons, MeCP2 diffusion resembles conventional transcription factors. One might speculate that the dominant role of the IDD in these environs is to assemble protein complexes through its NID domain when stably bound to DNA. In this scenario, the relative contributions of the IDD subdomains can vary dependent on cell type, local chromatin structure, and the epigenetic microenvironment, and the phenotypic consequences of specific mutations to MeCP2 would reflect the interplay between these factors and gene expression in each specialized cell type.

Concluding remarks {#s3-4}
------------------

Single molecule imaging studies of transcription factors in living nuclei have uncovered critical new features of their function that could not have been predicted based on biochemical or genomic approaches ([@bib11]; [@bib12]; [@bib21]; [@bib35]; [@bib36]; [@bib54]). Here we have presented a series of experiments that investigate in detail the molecular mechanisms that govern the dynamic behavior of MeCP2 in live neurons. Our results illustrate the complexity of MeCP2-chromatin interactions, which are sensitive to the level and state of cytosine methylation, depend on multiple protein domains, and differ depending on cell specific nuclear architecture. Although the dynamic behavior of MeCP2 resembles the linker histone H1.0, the specific features we have documented here allow MeCP2 function to be modulated locally as a result of changes in DNA methylation status and nuclear architecture. Given the variations evident in these determinants between cell type and in response to specific cues in a given neuronal lineage, our data support a dynamic role for MeCP2 in regulation of local chromatin structure.

Materials and methods {#s4}
=====================

Primary granule cell culture {#s4-1}
----------------------------

Cerebella of P6-P8 mice were dissected in cold CMF-PBS buffer (0.13M NaCl, 4 mM KCl, 11 mM Glucose, 3.6 mM NaH~2~PO~4~•H~2~O, 1.8 mM KH~2~PO~4~, 2.00 ml of 2% solution of NaHCO~3~, 0.5 ml of 0.5% solution of phenol red, pH 7.35, 1L of H~2~O), incubated in 37°C Trypsin-DNase (1 g/L DNase -Worthington Biochemical-, 10 g/L Trypsin -Worthington Biochemical-, 6 mM NaOH in CMF-PBS) for 5 min and triturated 10x in 1 ml RT DNase buffer (0.5 g/L DNase, 0.35% Glucose, in BME --GIBCO-) to obtain single cell suspension. Cells were pelleted by 5 min centrifugation at 1'500 rpm, resuspended in Granule Cell Medium (BME, L-Glu, Pen/Strep, 10% Horse Serum, 1% Glucose) and incubated for 1 hr at 37° C 5% CO~2~. After recovery, cells were pelleted by 5 min centrifugation at 1'500 rpm, responded in Granule Cell Medium and plated on poly-D-lysine coated 18 mm glass cover slip. Cells were then kept in culture (at 37°C, 5% CO~2~) for 12--14 days, exchanging half of the media with Serum-Free medium (DMEM w/o Phenol Red -GIBCO-, 25 mM HEPES, L-Glu, Pen/Strep, 1% glucose, B-27 and N2 supplement -GIBCO-) every 2 days. In case expressing vectors were inserted into the cells, following the 1 hr recovery, cells were washed 1x in RT PBS and transfected with \~15 μg of DNA plasmid using Amaxa nucleofector 2b (Lonza, program O-005). After transfection, cells were transferred in 10 ml RPMI (GIBCO) + 1% Glucose and incubated for 10 min at 37°C for recovery before being resuspended in Granule Cell Medium and plated on poly-D-lysine coated glass cover slip for culture.

Single molecule labeling and acquisition {#s4-2}
----------------------------------------

Culture cells were incubated with 5 nM of JF549 Halo-Ligand for 20 min and washed 3x with in Serum-Free medium. 2D single-molecule acquisition were conducted at 37°C in Serum-Free medium on a Nikon TI-Eclipse widefield Microscope equipped with a 100X Oil-immersion objective (Nikon, Plan Apo N.A. = 1.45), perfect focusing systems and DU-897 (iXon, Andor). Emission filter (Quad TIRF Set_Chroma, ZET 405/488/561/635, ET 600/50 m) was placed in front of the cameras for JF549 acquisition. We used a 561 nm laser (Agilent technologies) of excitation intensity \~100 W/cm^2^ to achieve sparse labeling. Acquisition times were 10 ms (100 Hz) at \~100 W/cm^2^ for mobile molecule tracks. The microscopy, lasers and the cameras were controlled through NIS-Elements (Nikon, US).

Single molecule analysis {#s4-3}
------------------------

2D single-molecule trajectories were determined using SLIMfast/evalSPT, a Matlab-based, modified version of MTT ([@bib47]); 5 μm^2^/s was set as maximum expected diffusion coefficient (D~max~), which determines the maximum distance (r~max~) between two frames for a particle translocation. Diffusion coefficients of individual molecules (D) were calculated from tracks with at least five consecutive frames and no more than 150 by MSDanalyzer with a minimal fitting R^2^ of 0.8 ([@bib53]). Fraction of bound molecules and diffusion coefficient of unbound molecules was determined per individual cell by using the SpotON 2-states (bound-free) kinetic model with 0.08 μm^2^/s as maximum D~bound~ and 0.15 μm^2^/s as minimum D~free~ ([@bib21]).

Dwell time analysis {#s4-4}
-------------------

Sparsely labeled nuclei were acquired at low laser power (\~18 W/cm^2^) at 2 Hz. 2D single molecule localizations were determined trough SLIMfast/evalSPT with D~max~ set at 0.05 μm^2^/s. The duration of individual tracks (dwell time) was directly calculated based on the track length. This was used to calculate survival probabilities to extract the average short-lived and long-lived residence times by fitting to double exponential decay.

Statistical analyses {#s4-5}
--------------------

Student t-test and ANOVA multipule comparison anlysese were performed using Prism (GraphPad Software, Inc). Kolmogorov-Smirnov test was performed using R Studio. For Kolmogorov-Smirnov test in panel 5C and 6B we used python 3.7 and the scipy library 0.14.

Generation of MeCP2haloTag Knock-In animals {#s4-6}
-------------------------------------------

### Targeting vector construction {#s4-6-1}

The targeting vector was constructed using the recombineering technique described in [@bib34].An 8,333 bp genomic DNA fragment containing exon 3 and 4 of the *Mecp2* gene was retrieved from BAC clone RP23-77L16 to a modified pBS vector containing the DT gene, a negative selection marker. A linker-Halo-tag transgene was inserted before TGA stop codon followed by an frt-NeoR-frt cassette for ES cell selection. The length of the 5' homologous arm is 3,226 bp and that for the 3' arm is 5,095 bp.

### ES cell targeting and screening {#s4-6-2}

The targeting vector was electroporated into F1 hybrid of 129S6 x C57BL/6J ES cells derived by Janelia Transgenic Facility. The G418 resistant ES clones were screened by nested PCR using primers outside the homologous arms paired with primers inside the Halo gene for 5' arm and the neo cassette for the 3' arm. The primers sequences were as follows:

5' arm screening primers: *Mecp2* Scr F1 (5'-AAAGCCAGCCTGCCTTGTTA −3') and HaloTag scr 5R1 (5'-CAACATCGACGTAGTGCATG −3'); The primers for the nested PCR are MECP Scr F2 (5'-ATGCACATGATGGGTACCTG −3') and HaloTag scr 5R2 (5'-CGATTTCAGTTGCCACTGGA −3').

3' arm screening primers: frt scr 3F1 (5'- TTCTGAGGCGGAAAGAACCA −3') and *Mecp2* scr 3R1 (5'- TGCTTTCAGTGCTAAGCAGG −3'); The primers for nested PCR are: frt scr 3F2 (5'-GGAACTTCATCAGTCAGGTAC −3') and MECP2 scr 3R2 (5'- CCAAGATGGCACTTAGTTCC-3').

### Generation of chimera and genotyping {#s4-6-3}

The PCR positive ES clones were expanded for generation of chimeric mice.

The ES cells were aggregated with 8 cell embryos of CD-1 strain. The neo cassette was removed by breeding germline chimeras with ROSA26FLP1 (Jax stock\#: 003946, Back crossed to C57bl/6 j for 13 generations) females.

The F1 pups were genotyped by PCR using primers *Mecp2* gt wt F (5'- GCTAAGACTCAGCCTATGGT −3'), *Mecp2* gt wt R (5'- AGGTCTTCAACCTGACTGTG-3'). The PCR products are 380 bp for the wildtype allele and 259 bp for the mutant allele. The primers for 3' end genotyping are HaloTag 3F (5'-ctactctggagatttccggt −3') and *Mecp2* gt wt R (5'-AGGTCTTCAACCTGACTGTG −3'). The PCR products is 327 bp for the mutant allele.

Mass spec on gDNA {#s4-7}
-----------------

Genomic DNA was extracted from isolated nuclei and fully digested with DNA Degradase Plus (Zymo Research). Samples were analyzed by mass spectrometry to quantify the amount of 5mCytosine and 5hmCytosine relative to Guanosine.

5hmc staining {#s4-8}
-------------

Primary cerebellar granule cells from Tet1^flox/flox^; Tet2^flox/flox^; Tet3^flox/flox^ animals were co-transfected with vectors expressing Cre and DIO-MeCP2HaloTag. After 14 days in culture on glass coverslips, cells were fixed in 4% PFA for 10 min. Samples were then incubated in 2N HCl for 30 min at 37°C, washed 3x with PBS and incubated in blocking buffer (PBS, 3% BSA, 0.01% Triton X) for 30 min at RT. Following blocking, coverslip were washed 1x in PBS and incubated with primary antibody anti-5hmC (1:500 in blocking buffer, Rb polyclonal, ActiveMotif) overnight at 4°C, washed 4x in PBST (PBS, 0.01% Triton X) and incubated with Secondary antibody (1:400 in blocking buffer, Donkey anti-Rb alxaflour 488 Jackson ImmunoResearch) and TMR-Halo-Ligand (2 nM, Promega). Cells were then washed 4x in PBST, labeled with DAPI and mounted on coverslip for acquisition with confocal microscopy.

DNA pull-down assay {#s4-9}
-------------------

293 cells were transfected with a vector expressing MeCP2HaloTag in Nuclear Extraction Buffer containing 0.5 mM DTT and protease inhibitor, and incubated on a orbital shaker for 60 min at 4°C. Samples were centrifuged at 16'000 x g for 5 min at 4°C to collect the nuclear protein extract in the supernatant. As in [@bib41], M280-straptavidin beads (8 μL per sample) were washed once in PBS 0.1% Triton X-100, and then incubated with 200 ng of biotinylated DNA probe in 300 μL of PBS, overnight at 4°C. Then beads were washed 2x in PBS 1% Triton X-100, 3X in Wash Buffer (0.2 mM EDTA, 20% Glycerol, 20 mM Hepes-KOH pH 7.9, 0.1 M KCl, 1 mM DTT, 1 mM protease inhibitor PMSF, 0.1% Triton X-100), and incubated with protein nuclear extract in Precipitation Buffer (0.05 mM EDTA, 5% Glycerol, 5 mM Hepes-KOH pH 7.9. 150 mM KCl, 1 mM DTT, 1 mM protease inhibitor PMSF, 0.025% Triton X-100 in PBS) for 15 min at 4°C. Beads were then washed 5X in Wash Buffer, 1X in PBS and eluted in LDS at 95°C for 10 min. MeCP2-HaloTag abundance in the eluted fractions was then determined by Western blot stained against HaloTag (Promega).

Synthetic probes used.

-   CpG DNA probe: acgtatatacgatttacgttatacgattacgatatacgatttacgttaatacgtttacgattattacgaatttacgtttttacgaatatacgaaatacgtttaatacgtaattacgtatattacgtatatacgatttacgaattacg.

-   CpA DNA probe: gcatatatgcaatttgcattatgcaattgcaatatgcaatttgcattaatgcatttgcaattattgcaaatttgcatttttgcaaatatgcaaaatgcatttaatgcataattgcatatattgcatatatgcaatttgcaaattgca.

Bisulfite sequencing {#s4-10}
--------------------

Whole genome bisulfite sequencing experiments were performed using TrueMethyl-Seq reagents and workflow, following manufacturer's instructions. In each condition, genomic DNA was extracted from granule cell nuclei isolated from adult male mice cerebella. At least 1 μg of DNA per sample was sonicated using Covaris-S2 system, DNA fragments of \~200 bp were end-repaired using TruSeq DNA Sample kit as per manufacturer's instructions. 4 ng of TrueMethyl sequencing spike-in controls were added to the DNA sample prior to adapter ligation. After TruSeq DNA adapters ligation, libraries were re-purified to eliminate potential contaminating compounds using 80% Acetonitrile and TrueMethyl-Seq magnetic beads. Following bisulfite conversion, desulfonation and purification, library amplifications were performed by PCR using TruSeq DNA primers and TrueMethyl-Seq reagents. Quality of libraries was assessed using High Sensitivity D1000 ScreenTape for the 2200 TapeStation system. Libraries were sequenced through HiSeq 2000. Sequencing data were aligned to UCSC mm10 *Mus musculus* genome using bsmap aligner (v2.87) ([@bib56]). MOABS ([@bib52]) methylation ratio calling module (mcall) was used to summarize the methylation levels of individual cytosines.

Single molecules recording on acute brain slice {#s4-11}
-----------------------------------------------

Adult MeCP2-HaloTag mice were decapitated under deep isoflurane anesthesia, and the brain was transferred to an ice-cold dissection solution containing (in mM): 125 NaCl, 2.5 KCl, 1.25 NaH~2~PO~4~, 25 NaHCO~3~, 25 dextrose, 1.3 CaCl~2~, 1 MgCl~2~ (pH 7.4, oxygenated with 95% CO~2~ and 5% O~2~). 150-µm-thick slices of the cerebellum were sectioned using a vibrating tissue slicer (Leica VT 1200S, Leica Microsystems, Wetzlar, Germany). The slices were then transferred to a suspended mesh within an incubation chamber filled with artificial cerebrospinal fluid (ACSF), same as the solution used for dissection. After 30--60 min of recovery at 35°C, the chamber was maintained at room temperature.

The lattice light sheet (LLS) microscope was used to perform 2D single-molecule imaging and tracking in mouse brain tissue ([@bib10]). In preparation of experiments, LLS scope was aligned and the imaging chamber with heating block was preheated to 37°C. Brains tissue were labeled with Janelia Dye JF549 at the concentration of 10 nM for 15mins. After repeated wash, the brain slices were adhered to the surface of 5 mm coverslips (Warner Instruments) and placed into the imaging chamber. The sample stage was moved to find representative Granule and Purkinje cells within the slice. Single-molecule imaging was then performed by exciting a single plane with a 560 nm laser at \~1333 W/cm^2^ at the rear aperture of the excitation objective, using Bessel beams arranged in a square lattice configuration in dithered mode. The fluorescence generated within the specimen was collected by a detection objective (CFI Apo LWD 25XW, 1.1 NA, Nikon), filtered through a 440/521/607/700 nm BrightLine quad-band bandpass filter (Semrock), and eventually recorded by an ORCA-Flash 4.0 sCMOS camera (Hamamatsu). Imaging was performed for 2000 continuous frames at 100 Hz. For dwelling time analysis we acquired 600 frames at 2 Hz under laser power \~26 W/cm^2^.

Nuclear isolation and FACS sorting {#s4-12}
----------------------------------

Nuclei isolation was performed as in [@bib57]. Cerebellum of adult (3--5 months old) mice was manually dissected and transfer to 5 ml of cold homogenization medium (0.25 M sucrose, 150 mM KCl, 5 mM MgCl2, 20 mM Tricine pH 7.8, 0.15 mM spermine, 0.5 mM spermidine, EDTA-free protease inhibitor cocktail, 1 mM DTT, 20 U/mL Superase-In RNase inhibitor, 40 U/mL RNasin ribonuclease inhibitor). Single nuclei suspensions were obtained by homogenization with glass dounce. Tissues were homogenized by 30 strokes of loose (A) followed by 30 strokes of tight (B) glass dounce. Nuclei were isolated by adding 50 mL of a 50% iodixanol solution (50% Iodixanol/Optiprep, 150 mM KCl, 5 mM MgCl2, 20 mM Tricine pH 7.8, 0.15 mM spermine, 0.5 mM spermidine, EDTA-free protease inhibitor cocktail, 1 mM DTT, 20 U/mL Superase-In RNase inhibitor, 40 U/mL RNasin ribonuclease inhibitor), to the homogenate and by laying the 10 ml of 25% iodixanol nuclear suspension on a 27% iodixanol cushion. Nuclei were pelleted by centrifugation 30 min, 10,000 rpm, 4°C in swinging bucket rotor (SW41) in a Beckman Coulter XL-70 ultracentrifuge. The nuclear pellet was resuspended in homogenization buffer.

FACS-sorting of Purkinjie cells was performed as in [@bib25]. The cerebellar nuclear suspension of Pcp2-TRAP animals (carrying Pcp2 BAC transgenic construct carrying IL10a-GFP fusion protein) was supplemented with DyeCycle Violet (Invirogen) to 20 μM final, as this DNA dye allows for the elimination of multiple nuclei aggregates that are recorded as a single event by the flow cytometer. Purkinje cells were identified by GFP signal and nuclei were sorted with BD FASCAria cell sorter using 405 nm and 488 nm excitation lasers.
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

The manuscript of Piccolo et al. studies the dynamics of Methyl-CpG-binding-protein in live neurons. Single-particle tracking of MeCP2 shows a mobile and immobile population, where the mobile population diffuses slower than gene specific transcription factors. The authors characterize in detail the contribution of DNA binding domain, the intrinsically disordered domain, and the AT-hook domain in the diffusion and DNA binding of MeCP2. In addition, the results show that the slow diffusion depends on non-specific chromatin interactions, and appear to be cell-type specific.

The presented experiments are well-performed and the results are convincing. The work shows new features of the complex behavior of MeCP2 and the authors present data to show how DNA methylation, chromatin compaction and specific protein sub-domains influence specific aspects of this behavior.

**Decision letter after peer review:**

Thank you for submitting your article \"MeCP2 nuclear dynamics in live neurons results from low and high affinity chromatin interactions\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including Job Dekker as the Reviewing Editor and Reviewer \#1, and the evaluation has been overseen by Huda Zoghbi as the Senior Editor.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Essential revisions:

1\) This is critical point: SpotOn is a key tool that the authors use to evaluate and interpret their data. As far as I understand SpotOn assumes only one bound and one unbound state. Are the assumptions of SpotOn correct for a DNA binding factor with more than one binding state, as seems the case for MeCP2?

2\) Possibly related to the previous point: MeCP2 shows very different diffusion behavior from other factors such as histones or Sox2. This also makes it more challenging to determine the individual bound and non-bound populations. For Sox2, the diffusion plot shows a bimodal population, but the MeCP2, the distribution is much broader and almost unimodal. In the mutants the distributions shifts, but it does not appear that the two populations are really separate. The bound fraction, and diffusion of bound molecules is then calculated as if these are really different populations. Could it be that this is just a single population, with binding sites of different affinity resulting in a broader distribution? Do the authors have any additional evidence to assume two different populations for MeCP2?

3\) The authors state: \"The rate of diffusion of the unbound R133C protein is measurably increased\". Figure 3D does not show that this effect of 133C on diffusion rate is statistically significant. Is it significant or not? If not then the authors cannot make this statement.

4\) Figure 5D: The number of observations in heterochromatin is much larger. When down-sampled to the same level as observed in the euchromatic domains, is the difference still significant?

5\) Is diffusion of MeCP2 in Purkinje cells still limited by the AT-hook domains? If not, then other interpretations for the altered mobility than altered chromatin compaction could explain the results.

6\) Since transfection efficiency can change between experiments, and between cells, it would be nice if the authors could show that the concentration of transfected MeCP2 is similar to the endogenous level. If no antibody is available to perform Western blots, the authors could perform FCS on the HaloTagged cells to determine the concentration in endogenously-tagged and transfected cells. This is especially important for all the mutated constructs where the mutations and truncations could affect protein level or stability, and lower concentration may affect the fraction bound.

7\) It somewhat disappointing that the difference in nuclear dynamics of MeCP2 in granule versus Purkinje cell was not examined in more detailed. For example, how similar are the affects of the Rett mutations on MeCP2 nuclear dynamics in these two types neurons?
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Author response

> Essential revisions:
>
> 1\) This is critical point: SpotOn is a key tool that the authors use to evaluate and interpret their data. As far as I understand SpotOn assumes only one bound and one unbound state. Are the assumptions of SpotOn correct for a DNA binding factor with more than one binding state, as seems the case for MeCP2?

We have now rewritten the first section of the Results to clarify this issue. In brief, there are two different types of imaging experiments that are used to reveal the dynamic properties of each protein included in the study.

The first is to acquire images at low excitation and long acquisition times (\~2Hz) to assess the residence times of stably bound molecules (Figure 1---figure supplement 1). The dwelling times in our study match those previously determined for Sox2, TBP and histone H2B in ES cells. In agreement with those studies, the dissociation kinetics of MeCP2 is best described by a double exponential decay that accounts for short-lived and long-lived populations of bound molecules (Figure 1---figure supplement 1B) for all proteins studied, including MeCP2 and histone H1.0. Furthermore, the short-lived bound molecules of MeCP2 have dwell times of \~ 2 seconds, similar to the sequence specific transcription factors Sox2 and TBP, and histone H1.0.

The second technique is to track individual molecules at high speed (100Hz) to reveal rapid diffusion dynamics. This allows one to assess the fraction of bound molecules because they diffuse very slowly (\<0.08μm^2^/s). However, long-lived and short-lived stable binding events cannot be distinguished in these experiments, and they are pooled into one number represented by the fraction bound. For the majority of data we have presented, we have used SpotOn to analyze fast tracking particles which we are able to monitor for no longer than \~2 seconds (200 frames at 10ms/frame) because the molecules are quickly bleached at high laser powers. SpotOn is used to model two states (bound and unbound) in each cell acquired at these high rates of imaging. It enables us to determine the fraction of MeCP2 that is stably bound, and the rapid rate of diffusion of unbound MeCP2 molecules that are imaged at these high speeds.

> 2\) Possibly related to the previous point: MeCP2 shows very different diffusion behavior from other factors such as histones or Sox2. This also makes it more challenging to determine the individual bound and non-bound populations. For Sox2, the diffusion plot shows a bimodal population, but the MeCP2, the distribution is much broader and almost unimodal. In the mutants the distributions shifts, but it does not appear that the two populations are really separate. The bound fraction, and diffusion of bound molecules is then calculated as if these are really different populations. Could it be that this is just a single population, with binding sites of different affinity resulting in a broader distribution? Do the authors have any additional evidence to assume two different populations for MeCP2?

Studies from several laboratories (Nan et al., 1993; Mellen et al., 2012; Gabel et al., 2015) have demonstrated that high affinity binding of MeCP2 to methylated DNA (Kd \~ 1x10^-9^M) is similar to the binding of sequence specific transcription factors to their cognate binding sites. As discussed above, the residence time data we have presented confirms this fact and demonstrates that the short-lived stable interactions of MeCP2, Histone H1.0, Sox2 and TBP are similar. Based on these data, and previous studies of Sox2 and TBP in ES cells (Chen et al., 2014b), a diffusion coefficient of \<0.08 μm^2^/s was chosen to calculate the fraction of stably bound MeCP2.

The conclusion that the unbound fraction of MeCP2 is not engaged in stable binding interactions with high affinity binding sites (5mCpG, 5mCpH, 5hmCpH) is supported by the fact that its average diffusion (\~1μm^2^/s) is more an order of magnitude faster than the values demonstrated for high affinity transcription factor interactions, and by our structure/function studies indicating that domains of MeCP2 outside of the MBD can impact its diffusion in the presence of a mutation (R106W) that completely abolishes stable binding.

The plots of diffusion coefficients shown in Figure 1E appear mono-modal because the diffusion of many more of the unbound MeCP2 molecules is slower than that measured for TBP or Sox2 despite the fact they are not stably bound to high affinity sites (note this is a logarithmic scale). Changes in the shapes of these plots are informative, and they almost certainly reflect a range of low affinity interactions with DNA or proteins that are mediated by the AT-Hook and NID domains. SpotOn analyzes unbound molecules as a single population to provide an average diffusion coefficient so that one can compare quantitatively the behavior of the entire unbound population.

> 3\) The authors state: \"The rate of diffusion of the unbound R133C protein is measurably increased\". Figure 3D does not show that this effect of 133C on diffusion rate is statistically significant. Is it significant or not? If not then the authors cannot make this statement.

We have now modified the manuscript to reflect the reviewers' comments. Although, as indicated by the reviewer, the difference in the average diffusion of MeCP2 R133C per cell is not statistically significant (Figure 3D), the distribution of diffusion coefficients is noticeably shifted and there is a significant trend toward higher diffusion coefficients (Figure 3C). We think it is important to point this out to the reader, and we have done so in very conditional terms. R133C results in increased diffusion coefficient, but this is a very subtle effect that is not measured by SpotOn fitting model over all the cells analyzed (Figure 3D).

> 4\) Figure 5D: The number of observations in heterochromatin is much larger. When down-sampled to the same level as observed in the euchromatic domains, is the difference still significant?

To understand whether this might alter the conclusions we have reached, we have performed additional statistical tests. Thus, we sub-sampled euchromatic data to match the number of particles recorded in heterochromatin and calculate the p value with Kolmogorov--Smirnov test from data presented in Figure 5C (all cells) and in 5D (individual representative cells). In order to minimize data loss, we repeated this analysis in 1000 iterations of randomly selected particle values from the pool of euchromatin. In [Author response image 1](#respfig1){ref-type="fig"} we plotted the log10 distribution of the p-values calculated. These data nicely confirm the statistic reported on panel 5D and indicate that the difference is not due to a sampling bias (The red dashed lines represent p-value=0.05).
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> 5\) Is diffusion of MeCP2 in Purkinje cells still limited by the AT-hook domains? If not, then other interpretations for the altered mobility than altered chromatin compaction could explain the results.

While it would be very nice to test this directly, transfection of mutant constructs into Purkinje cells in slice preparations is exceedingly inefficient, and the technical difficulties associated with imaging very sparsely expressing cells in these preparations have prevented structure/function studies of this type. However, we believe the very different dynamic behaviors of MeCP2 molecules in these two very different nuclear types are fascinating and should be presented.

Of course, the implications of our data are many and significant. As alluded to by the reviewers, they certainly suggest that the IDD domain of MeCP2 (including the AT Hooks) has very little effect on diffusion in Purkinje cells and other nuclei of this type, and that this difference may have important functional consequences. Rather than enumerate these possibilities and speculate on the causes of this behavior (higher levels of 5hmC, differences in 3D chromatin architecture, altered levels of histone H1, etc..), we chose to make a very general statement that we believe is consistent with the data we have presented. If there are other interpretations of the data or the reviewer would like to suggest different language, we could edit the text appropriately.

> 6\) Since transfection efficiency can change between experiments, and between cells, it would be nice if the authors could show that the concentration of transfected MeCP2 is similar to the endogenous level. If no antibody is available to perform Western blots, the authors could perform FCS on the HaloTagged cells to determine the concentration in endogenously-tagged and transfected cells. This is especially important for all the mutated constructs where the mutations and truncations could affect protein level or stability, and lower concentration may affect the fraction bound.

To address this concern, in [Author response image 2](#respfig2){ref-type="fig"} we calculated total nuclear fluorescence of endogenous expressing MeCP2 HaloTag as well as the transfected HaloTag constructs used in Figure 4 and labelled with HaloLigand JF549 in representative cells. Nuclear fluorescence of each representative cell was normalized to background levels outside the nucleus of each cell. As expected, transfected samples display lower signal/noise ratios than endogenous expressed MeCP2HaloTag, and the levels measured for each construct are similar.

![](elife-51449-resp-fig2){#respfig2}

Additionally, in Figure 1 and extensively in Figure 1---figure supplement 3 we show that endogenously and exogenously expressed HaloTag constructs behave identically indicating that levels of MeCP2 expression do not impact on its dynamic behavior in our analysis.

> 7\) It somewhat disappointing that the difference in nuclear dynamics of MeCP2 in granule versus Purkinje cell was not examined in more detailed. For example, how similar are the affects of the Rett mutations on MeCP2 nuclear dynamics in these two types neurons?

See response to point 5. This analysis is beyond the scope of this paper given existing technology for exogenous expression in Purkinje cells.
